Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter study.
Masanori AtsukawaAkihito TsubotaHidenori ToyodaKoichi TakaguchiChisa KondoTomomi OkuboAtsushi HiraokaKojiro MichitakaShinichi FujiokaHaruki UojimaTsunamasa WatanabeHiroki IkedaToru AsanoToru IshikawaYoshihiro MatsumotoHiroshi AbeKeizo KatoKunihiko TsujiChikara OgawaNoritomo ShimadaEtsuko IioShigeru MikamiYasuhito TanakaTakashi KumadaKatsuhiko IwakiriPublished in: Journal of gastroenterology and hepatology (2018)
The present study demonstrated that elbasvir and grazoprevir are highly effective and safe for genotype 1b chronic hepatitis C Japanese patients with CKD, including those undergoing hemodialysis.